VetStem Biopharma
PrivateLast Round
Strategic
Mar 18, 2025
Total Funding Raised
$2.55M
Company Overview
VetStem Biopharma is a biotechnology company that provides regenerative stem cell services and therapies for cats, dogs, and horses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VetStem Biopharma Comparables
Compare VetStem Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ardent Animal Health | 88% | |
| Animal Cell Therapies, Inc. | 87% | |
| eQcell Inc. | 86% | |
VetStem Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 18, 2025 | ||||
| Debt | Apr 16, 2020 |
VetStem Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Toucan Capital Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 40% MoM.
- May 4, 2025
Monthly visitors grew 50% MoM.
VetStem Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VetStem Biopharma's valuation, stock price, and market status.